Death rate from cardiomyopathy, myocarditis and endocarditis in Latvia
Latvia: Death rate from cardiomyopathy, myocarditis and endocarditis was 37.56 deaths per 100,000 people in 2021. ▲ Rising
Death rate from cardiomyopathy, myocarditis and endocarditis in Latvia, 2000–2021
Source: World Health Organization (2024) – with major processing by Our World in Data. Measured in deaths per 100,000 people.
Analysis
The most recent figure for death rate from cardiomyopathy, myocarditis and endocarditis in Latvia is 37.56 deaths per 100,000 people, measured in 2021.
That represents a change of up 49.4% on the previous year and up 44.8% over ten years.
Over the whole period, death rate from cardiomyopathy, myocarditis and endocarditis in Latvia peaked at 40.61 deaths per 100,000 people in 2006 and was at its lowest, 21.2 deaths per 100,000 people, in 2000.
Latvia ranks 3rd of 194 countries on this measure, in the top 10%.
The long-run direction has been consistently rising across the 22 years of available data.
Death rate from cardiomyopathy, myocarditis and endocarditis in Latvia, year by year
| Year | deaths per 100,000 people | Change |
|---|---|---|
| 2000 | 21.2 deaths per 100,000 people | — |
| 2001 | 24.65 deaths per 100,000 people | +16.3% |
| 2002 | 26.61 deaths per 100,000 people | +8.0% |
| 2003 | 29.86 deaths per 100,000 people | +12.2% |
| 2004 | 30.7 deaths per 100,000 people | +2.8% |
| 2005 | 36.16 deaths per 100,000 people | +17.8% |
| 2006 | 40.61 deaths per 100,000 people | +12.3% |
| 2007 | 39.47 deaths per 100,000 people | -2.8% |
| 2008 | 32.36 deaths per 100,000 people | -18.0% |
| 2009 | 27.13 deaths per 100,000 people | -16.2% |
| 2010 | 27.96 deaths per 100,000 people | +3.0% |
| 2011 | 25.95 deaths per 100,000 people | -7.2% |
| 2012 | 27.76 deaths per 100,000 people | +7.0% |
| 2013 | 28.93 deaths per 100,000 people | +4.2% |
| 2014 | 28.78 deaths per 100,000 people | -0.5% |
| 2015 | 28.53 deaths per 100,000 people | -0.9% |
| 2016 | 29.5 deaths per 100,000 people | +3.4% |
| 2017 | 32.91 deaths per 100,000 people | +11.6% |
| 2018 | 32.26 deaths per 100,000 people | -2.0% |
| 2019 | 29.04 deaths per 100,000 people | -10.0% |
| 2020 | 25.15 deaths per 100,000 people | -13.4% |
| 2021 | 37.56 deaths per 100,000 people | +49.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 30.87 deaths per 100,000 people | 21.2 deaths per 100,000 people | 40.61 deaths per 100,000 people | 10 |
| 2010s | 29.16 deaths per 100,000 people | 25.95 deaths per 100,000 people | 32.91 deaths per 100,000 people | 10 |
| 2020s | 31.35 deaths per 100,000 people | 25.15 deaths per 100,000 people | 37.56 deaths per 100,000 people | 2 |
Countries ranked near Latvia
- 1 Serbia 82.2 deaths per 100,000 people compare
- 2 North Macedonia 48.9 deaths per 100,000 people compare
- 4 Kazakhstan 31.11 deaths per 100,000 people compare
- 5 Russian Federation 25.06 deaths per 100,000 people compare
- 6 Central African Republic 19.78 deaths per 100,000 people compare
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,593 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Population ages 50-54, male, annual growth rate -0.4304 % change on previous year (2025)
- Population ages 50-54, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 50-54, male, per capita 0.0334 units per person (2025)
- Population ages 55-59, female, annual growth rate -0.4999 % change on previous year (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per capita 0.0359 units per person (2025)
Frequently asked questions
- What is death rate from cardiomyopathy, myocarditis and endocarditis in Latvia?
- Death rate from cardiomyopathy, myocarditis and endocarditis in Latvia was 37.56 deaths per 100,000 people in 2021, according to World Health Organization (2024) – with major processing by Our World in Data.
- What is the highest death rate from cardiomyopathy, myocarditis and endocarditis recorded in Latvia?
- The highest recorded value was 40.61 deaths per 100,000 people in 2006.
- What is the lowest death rate from cardiomyopathy, myocarditis and endocarditis recorded in Latvia?
- The lowest recorded value was 21.2 deaths per 100,000 people in 2000.
- How does Latvia rank for death rate from cardiomyopathy, myocarditis and endocarditis?
- Latvia ranks 3rd out of 194 countries with data for 2021.
- Is death rate from cardiomyopathy, myocarditis and endocarditis rising or falling in Latvia?
- Over the last ten years it is up 44.8%. The long-run trend across the full record is rising.
- Where does this Latvia data come from?
- The figures come from World Health Organization (2024) – with major processing by Our World in Data, published as part of Death rate from cardiomyopathy, myocarditis and endocarditis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Estimated number of age-standardized deaths from cardiomyopathy, myocarditis, endocarditis in both sexes, per 100,000 people.